USIran Standoff Deepens as Trump Rejects Peace Counteroffer Threatening Global Energy Supplies
Suzlon Q4FY26 Profit Dip 575 as Revenue Jumps 45 on Record Wind Turbine Deliveries
Tokenization Could Reshape Banking Landscape Strategys Michael Saylor Suggests
Oil Price Reversal Highlights Persistent Geopolitical Risk Premium in Crude Markets
Chinas Commerce Minister Skips APEC Opening Amid Urgent Official Business Trade Representative Chairs Meeting
Move Over Tesla Another RoboTaxi Stock Accelerates Its Autonomous Ambitions
Edgewell Personal Care EPC Q1 2026 Earnings EPS Misses Estimates but Shares Gain
ASTC Q1 2024 Earnings Reported Loss of 179 Per Share Amidst Market Challenges
ARL Q3 2024 Earnings Loss Per Share Widens Amidst Challenging Real Estate Market
LASR Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Amid Strategic Shifts
Virtu Financial Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher
Fulcrum Therapeutics Q1 2026 Earnings Narrowing Losses as Pipeline Advances
Strata Critical Medical SRTA Holds Steady Near Key Resistance Level
PGIM High Yield Bond Fund ISD Holds Steady at 1299 as Income Investors Seek Stability
PLBY Retreats to 128 Bearish Momentum Tests Critical Support
Sentage Holdings Inc SNTG Edges Higher Amid Consolidation Near Key Resistance
Ford Motor Company F Pushes Higher After Positive Session
Market Expectations Shift Toward Fed Rate Hike After Hot Inflation Data
STKS Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Operational Headwinds
Charter Communications CHTR Holds Near Support as Modest Decline Continues
Perella Weinberg Partners Q1 2026 Earnings EPS Misses Estimates as Advisory Revenue Remains Undisclosed
GECCI Q1 2026 Earnings Strong EPS Beat Driven by Improved Investment Income
NWFL Q1 2026 Earnings Strong EPS Beat Amid Challenging Environment
TD Q1 2026 Earnings EPS Beat Bolsters Investor Confidence Amidst Ongoing Regulatory Challenges
GNPX Q1 2026 Earnings ClinicalStage Biotech Reports Net Loss with No Revenue Stock Moves Up 074
TLN Q1 2026 Earnings EPS Falls Far Short of Estimates Yet Shares Edge Higher
Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress